Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Ocugen Inc (NASDAQ: OCGN) closed at $0.96 in the last session, up 0.86% from day before closing price of $0.95. In other words, the price has increased by $0.86 from its previous closing price. On the day, 2.81 million shares were traded. OCGN stock price reached its highest trading level at $0.9771 during the session, while it also had its lowest trading level at $0.91.
Ratios:
We take a closer look at OCGN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.04 and its Current Ratio is at 1.04. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on October 15, 2024, initiated with a Buy rating and assigned the stock a target price of $4.
On March 01, 2023, Chardan Capital Markets Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $3.50.
On August 23, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.Mizuho initiated its Buy rating on August 23, 2022, with a $5 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 16 ’24 when RAMESH KUMAR bought 116,705 shares for $1.25 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OCGN now has a Market Capitalization of 275624000 and an Enterprise Value of 266791808. For the stock, the TTM Price-to-Sale (P/S) ratio is 80.68 while its Price-to-Book (P/B) ratio in mrq is 14.56. Its current Enterprise Value per Revenue stands at 36.733 whereas that against EBITDA is -5.282.
Stock Price History:
Over the past 52 weeks, OCGN has reached a high of $2.11, while it has fallen to a 52-week low of $0.35. The 50-Day Moving Average of the stock is -9.41%, while the 200-Day Moving Average is calculated to be -24.31%.
Shares Statistics:
According to the various share statistics, OCGN traded on average about 3.63M shares per day over the past 3-months and 3366430 shares per day over the past 10 days. A total of 287.86M shares are outstanding, with a floating share count of 283.71M. Insiders hold about 1.44% of the company’s shares, while institutions hold 23.93% stake in the company. Shares short for OCGN as of 1728950400 were 51917995 with a Short Ratio of 14.30, compared to 1726185600 on 50901819. Therefore, it implies a Short% of Shares Outstanding of 51917995 and a Short% of Float of 18.35.
Earnings Estimates
A comprehensive evaluation of Ocugen Inc (OCGN) is underway, with the input of 3.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.04 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.17 and -$0.25 for the fiscal current year, implying an average EPS of -$0.21. EPS for the following year is -$0.25, with 3.0 analysts recommending between -$0.17 and -$0.32.
Revenue Estimates
A total of 4 analysts have provided revenue estimates for OCGN’s current fiscal year. The highest revenue estimate was $4.6M, while the lowest revenue estimate was $2.1M, resulting in an average revenue estimate of $2.75M. In the same quarter a year ago, actual revenue was $6.04M
